Trial intelligence / Profile preview

Cetrorelix SR in Endometriosis

NCT00244452Phase 2Completed

Sponsor
Solvay
Start
Nov 2005
Primary completion
Sep 2006
Modality
Peptides, Small Molecules
Countries
8
01

Overview

A Phase 2 trial of cetrorelix in endometriosis, sponsored by Solvay. Started Nov 2005; status: completed.

02

Drugs

cetrorelix
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT00244452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00244452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call